TrialAntimicrobial agents and chemotherapy2022

Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study.

Cindy Vavro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.